Endometrial Neoplasms
Conditions
Brief summary
This randomized trial is studying the efficacy and safety of the hysterectomy alone compared with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA endometrial carcinoma.
Interventions
Total hysterectomy
Total hysterectomy and bilateral salpingo-oophorectomy
bilateral pelvic and para-aortic lymph node dissection
Sponsors
Study design
Eligibility
Inclusion criteria
* FIGO stage: ⅠA, endometrial carcinoma; * Female, Chinese women; * premenopausal women; * ≤ 50 years old; * Pathological diagnosis by curettage/hysteroscopy : G1 * No prior treatment; * Provide written informed consent.
Exclusion criteria
* The suspicious metastasis of ovarian; * Family history of ovarian cancer; * Suffering from other malignancies; * Concurrently participating in other clinical trials; * Unable or unwilling to sign informed consents; * Unable or unwilling to abide by protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival (DFS) | 3-year DFS |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical gynecologic endocrine function | 1-year period | To observe the level of female hormone,i.e., estrogen, FSH, LH |
| Quality of Life | 3-year period | — |
| Overall Survival (OS) | 3-year OS | — |
Countries
China